[Pulmonary infections in patients with rheumatoid arthritis]

Noboru Takayanagi1, Yutaka Tsuchiya, Daidou Tokunaga

  • 1Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center.

Insights

Rheumatoid arthritis patients face diverse pulmonary infections, including nontuberculous mycobacteriosis and pneumonia. Underlying lung disease and immunosuppressive therapies are key risk factors for these infections.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Pulmonology

Context:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting joints and potentially other organs.
  • Pulmonary complications are a significant cause of morbidity and mortality in RA patients.
  • Understanding the spectrum and risk factors of pulmonary infections in RA is crucial for patient management.

Purpose:

  • To investigate the types and prevalence of pulmonary infections in rheumatoid arthritis patients.
  • To identify underlying conditions and treatments associated with increased risk of pulmonary infections in RA.
  • To analyze the specific risk factors contributing to different types of pulmonary infections in this population.

Summary:

  • A study of 149 RA patients revealed various pulmonary infections, with nontuberculous mycobacteriosis (59 cases) and pneumonia (46 cases) being most common.
  • Underlying lung diseases were prevalent, especially in patients with exacerbation of bronchiectasis (100%), pulmonary aspergillosis (91.7%), and pneumonia (87%).
  • Immunosuppressive therapies like steroids, methotrexate, and TNFalpha inhibitors were associated with specific infections, while comorbidities like malignancy and diabetes mellitus were noted in lung abscess cases. Pseudomonas aeruginosa was a common pathogen.

Impact:

  • This research highlights the complex interplay of factors contributing to pulmonary infections in RA patients.
  • It underscores the importance of considering underlying lung disease, specific immunosuppressive treatments, and comorbidities when assessing infection risk.
  • Findings can inform clinical practice, leading to better diagnostic strategies and preventative measures for pulmonary infections in rheumatoid arthritis.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: